Venture Capital

As Dye & Durham preps its Q3 earnings call, all eyes are on its transformation plan after a streak of declining revenue and significant net losses.

A new alliance aims to develop first-in-class drugs for Alzheimer's and Parkinson's by targeting chronic brain inflammation, a key driver of disease.

The medical device maker posts its 14th straight growth quarter, with soaring profits and a strategic focus on the underserved bronchiectasis market.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

The parent of Stop & Shop and Food Lion has hired a top data scientist. Here's how this move will reshape your shopping experience and the grocery industry.

Replit's new vibecon conference, featuring Spike Jonze and Refik Anadol, aims to merge code and culture. But is it a strategic pivot or a new creative renaissance?

A Boston-area biotech is tackling a key bottleneck in drug manufacturing, promising to unlock a new generation of RNA therapeutics with its novel platform.

Daimler-backed Torc Robotics hires ex-Alphabet exec Tobias Wessels, signaling a major push to get its Level 4 autonomous trucks on the road by 2027.

By rethinking a 50-year-old component, Aqua Membranes is poised to revolutionize water treatment and contend for the $119M XPRIZE Water Scarcity prize.

Locus Technologies' major GIS+ update aims to streamline compliance and create a single platform for all environmental, water, and ESG data.

A new subscription box offers tea parties and protein bars for dogs. Genius Dog is betting that modern owners will pay for elevated, shared experiences.

A staggering 50% of first-time C-suite leaders fail within 18 months, costing billions. A new book by a veteran advisor aims to fix this preparation gap.

Hong Kong security firm SU Group is raising $6M via a complex warrant offering, stirring investor debate on whether it's for growth or a financial lifeline.

A new CISO-voted list reveals the 30 startups trusted to secure the AI era as a new report warns that AI adoption is dangerously outpacing security readiness.

S2G Investments launches a $1B fund to scale growth-stage firms in food, energy, and oceans, bridging a critical financing gap for market-ready solutions.

Impulse Biomedical, a Cape Town startup, enters the US market via a Maryland program, bringing a reloadable epi-pen and an ergonomic inhaler sleeve.

Fueled by personal tragedy and backed by tech titans, a new foundation aims to revolutionize lung cancer detection using AI and genetics for non-smokers.

Jessar Industries launches smart appliance and premium cookware lines, backed by a major digital push to capture a larger share of the modern home market.